Published in Front Pharmacol on April 14, 2014
Acupuncture for visceral pain: neural substrates and potential mechanisms. Evid Based Complement Alternat Med (2014) 0.82
Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 8.11
Somatostatin and its receptor family. Front Neuroendocrinol (1999) 3.69
The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci (2005) 2.68
Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate. Gastroenterology (2013) 2.56
Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes. Gut (2012) 2.36
Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev (1994) 2.13
Post-inflammatory colonic afferent sensitisation: different subtypes, different pathways and different time courses. Gut (2009) 1.91
Amovement receptor of the small intestine. J Physiol (1966) 1.75
Sensory transmission in the gastrointestinal tract. Neurogastroenterol Motil (2007) 1.71
Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology (2008) 1.63
GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol (1999) 1.60
Encoding of visceral noxious stimuli in the discharge patterns of visceral afferent fibres from the colon. Pflugers Arch (1983) 1.25
Intracolonic zymosan produces visceral hyperalgesia in the rat that is mediated by spinal NMDA and non-NMDA receptors. Brain Res (1996) 1.21
Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol (2006) 1.17
A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention. Gastroenterology (1993) 1.17
Identification of medium/high-threshold extrinsic mechanosensitive afferent nerves to the gastrointestinal tract. Gastroenterology (2009) 1.07
Somatostatin sst(2) receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology (2001) 1.05
Extrinsic primary afferent signalling in the gut. Nat Rev Gastroenterol Hepatol (2013) 1.03
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep (2011) 0.99
The role of galanin as a multi-functional neuropeptide in the nervous system. Curr Opin Pharmacol (2001) 0.97
Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients. J Pharmacol Exp Ther (1994) 0.94
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil (2008) 0.93
Activation of lamina I spinal cord neurons that express the substance P receptor in visceral nociception and hyperalgesia. J Pain (2002) 0.93
Effects of octreotide on responses to colorectal distension in the rat. Gut (2001) 0.93
Glucagon-like peptide-1 inhibits voltage-gated potassium currents in mouse nodose ganglion neurons. Neurogastroenterol Motil (2009) 0.91
Activation of guanylate cyclase-C attenuates stretch responses and sensitization of mouse colorectal afferents. J Neurosci (2013) 0.91
Octreotide reduces perception of rectal electrical stimulation by spinal afferent pathway inhibition. Am J Physiol (1995) 0.91
Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study. Aliment Pharmacol Ther (2008) 0.89
Anti-hyperalgesic effect of octreotide in patients with irritable bowel syndrome. Aliment Pharmacol Ther (2004) 0.89
Revisiting concepts of visceral nociception in irritable bowel syndrome. Eur J Pain (2012) 0.88
Peripheral glucagon-like peptide-1 (GLP-1) and satiation. Physiol Behav (2011) 0.87
Peripheral opioid modulation of visceral pain. Ann N Y Acad Sci (2000) 0.85
Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation. Expert Rev Gastroenterol Hepatol (2013) 0.85
Spontaneous hypersensitivity in mesenteric afferent nerves of mice deficient in the sst2 subtype of somatostatin receptor. J Physiol (2007) 0.83
The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility. Neurogastroenterol Motil (2008) 0.83
Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review. Clin Exp Gastroenterol (2012) 0.82
Involvement of galanin receptors 1 and 2 in the modulation of mouse vagal afferent mechanosensitivity. J Physiol (2007) 0.81
Increased κ-opioid receptor expression and function during chronic visceral hypersensitivity. Gut (2013) 0.80